Attention Deficit Hyperactivity Disorder among Clients Diagnosed with a Substance Use Disorder in the Therapeutic Communities: Prevalence and Psychiatric Comorbidity
| Autor: | Lenka Šťastná, Martin Šefránek, Eva Rubášová, Michal Miovský, Roman Gabrhelík, Kateřina Lukavská |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Health (social science) Substance-Related Disorders Psychological intervention 030508 substance abuse Medicine (miscellaneous) Comorbidity behavioral disciplines and activities Cohort Studies 03 medical and health sciences 0302 clinical medicine mental disorders Epidemiology Prevalence medicine Humans Attention deficit hyperactivity disorder Psychiatry Therapeutic Community business.industry Therapeutic community medicine.disease Mental health 030227 psychiatry Substance abuse Psychiatry and Mental health Attention Deficit Disorder with Hyperactivity Female 0305 other medical science business Cohort study |
| Zdroj: | European Addiction Research. 27:87-96 |
| ISSN: | 1421-9891 1022-6877 |
| Popis: | Background: Most severe substance use disorders (SUDs) are connected with attention deficit hyperactivity disorder (ADHD) and other mental health problems. Therapeutic communities (TCs) provide a suitable option for the treatment of severe SUDs. The relationship between ADHD, the severity of the SUD, and other comorbidities in residential TCs is unknown. Objective: To estimate the prevalence of ADHD among clients with an SUD in residential rehab, and to compare the mental health of clients with and without ADHD. Methods: A cohort study was conducted in 5 residential TCs (N = 180, 76.7% male, 53.9% 25–34 years, 79.2% diagnosed with methamphetamine use disorder). We assessed ADHD symptoms, substance use, mental health problems, and psychiatric symptoms. Results: ADHD was found in 51% of the clients who showed significantly higher scores for their psychiatric status composite score (ASI-PSY) (F = 9.08, p < 0.001; t = 5.05, p < 0.001), the positive psychiatric symptoms total (SCL-PST) (F = 3.36, p < 0.05; t = 3.15, p < 0.01), and the global severity index (SCL-GSI) (F = 3.27, p < 0.05; t = 3.18, p < 0.01). The ASI-PSY and SCL correlated significantly with the symptoms of attention deficit disorder (Pearson’s r’s = 0.30–0.42, p’s < 0.001) and the symptoms of hyperactivity disorder (r’s = 0.24–0.30, p’s < 0.01). Even when severity of substance use was accounted for, ADHD was confirmed as a significant predictor of ASI-PSY (B= 0.14, p < 0.001 for combined disorder; B = 0.20, p < 0.001 for attention disorder) and partially of SCL-PST (B = 8.12, p < 0.05 for attention disorder). Conclusions: The ADHD prevalence in TCs was nearly 10-fold compared to the globally recorded values. ADHD diagnostic procedures and interventions should become an integral part of the standard diagnostic and treatment process. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|